Literature DB >> 9462629

Daily energy and substrate metabolism in patients with cirrhosis.

A V Greco1, G Mingrone, G Benedetti, E Capristo, P A Tataranni, G Gasbarrini.   

Abstract

Twenty-four-hour energy expenditure (EE) and substrate oxidation (respiratory chamber), and whole-body glucose uptake and oxidation rates (euglycemic hyperinsulinemic clamp [EHC] and indirect calorimetry) were measured in 10 male patients with posthepatitis, Child B cirrhosis, and 8 healthy male controls matched for age, body size, and body composition. Twenty-four-hour EE was higher in cirrhotic patients than in controls (8,567 +/- 764 vs. 6,825 +/- 507 kJ/d; P < .001). Resting energy expenditure (REE) was also higher in cirrhotic patients than in controls (7,881 +/- 1,125 vs. 5,868 +/- 489 kJ/d; P < .01). Twenty-four-hour respiratory quotient (RQ) (trend) and fasting RQ (0.76 +/- 0.05 vs. 0.82 +/- 0.04; P < .05) were lower in cirrhotic patients than in controls, reflecting higher lipid oxidation rates in the former group. Whole-body glucose uptake was markedly reduced in cirrhotic patients when compared with controls (22.4 +/- 3.2 vs. 44.5 +/- 7.6 mmol/kg/min; P < .001). Carbohydrate oxidation rates, computed during the last 40 minutes of the clamp, were 8.5 +/- 1.1 mmol/kg/min in cirrhotic patients and 22.6 +/- 6.1 mmol/kg/min in controls (P < .001). Nonoxidative glucose disposal was 13.9 +/- 2.5 mmol/kg/min in cirrhotic patients and 22.0 +/- 5.5 mmol/kg/min in normal controls (P < .01). In conclusion, our data indicate that patients with Child B cirrhosis who still maintain a nutritional status (i.e., body composition) comparable with healthy controls are characterized by a cluster of metabolic defects that include hypermetabolism, increased lipid utilization, and insulin resistance. This suggests that the above metabolic syndrome precedes and probably leads to malnutrition in the natural history of the liver disease. In fact, in spite of the absence of a significant difference in caloric intake between cirrhotic patients and normal controls, the elevated 24-hour EE might allow for a relevant weight loss in cirrhotic patients, because, with time, the differences may be cumulative. However, whether this hypermetabolism can lead to a real weight loss remains to be evaluated in a longitudinal study.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9462629     DOI: 10.1002/hep.510270205

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  15 in total

1.  Nutrition in hepatic failure and liver transplantation.

Authors:  J Aranda-Michel
Journal:  Curr Gastroenterol Rep       Date:  2001-08

2.  Handheld calorimeter is a valid instrument to quantify resting energy expenditure in hospitalized cirrhotic patients: a prospective study.

Authors:  Cathy Glass; Peggy Hipskind; Denise Cole; Rocio Lopez; Srinivasan Dasarathy
Journal:  Nutr Clin Pract       Date:  2012-06-05       Impact factor: 3.080

3.  Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions.

Authors:  A V Greco; G Mingrone; A Mari; E Capristo; M Manco; G Gasbarrini
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

Review 4.  Gastrointestinal dysfunction in liver cirrhosis.

Authors:  Evangelos Kalaitzakis
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

5.  Leptin levels in the differential diagnosis between benign and malignant ascites.

Authors:  Mehmet Buyukberber; Mehmet Koruk; M-Cemil Savas; Murat-T Gulsen; Yavuz Pehlivan; Rukiye Deveci; Alper Sevinc; Serdar Gergerlioglu
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

Review 6.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

7.  Nutritional status in relation to lifestyle in patients with compensated viral cirrhosis.

Authors:  Fumikazu Hayashi; Chika Momoki; Miho Yuikawa; Yuko Simotani; Etsushi Kawamura; Atsushi Hagihara; Hideki Fujii; Sawako Kobayashi; Shuji Iwai; Hiroyasu Morikawa; Masaru Enomoto; Akihiro Tamori; Norifumi Kawada; Satoko Ohfuji; Wakaba Fukusima; Daiki Habu
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

8.  High ascitic fluid leptin levels in patients with decompensated liver cirrhosis and sterile ascites: relationship with TNF-alpha levels.

Authors:  Edoardo Giannini; Paola Romagnoli; Gian Luca Tenconi; Federica Botta; Federica Malfatti; Bruno Chiarbonello; Mario Mamone; Tommaso Barreca; Roberto Testa
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

Review 9.  Nutrition management in chronic liver disease.

Authors:  Ashish Bavdekar; Sheila Bhave; Anand Pandit
Journal:  Indian J Pediatr       Date:  2002-05       Impact factor: 1.967

10.  The Challenges of Nutritional Assessment in Cirrhosis.

Authors:  Alessio Molfino; Sheeva Johnson; Valentina Medici
Journal:  Curr Nutr Rep       Date:  2017-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.